Literature DB >> 20635995

T-cell-directed treatment strategies for Type 1 diabetes and the confounding role of inflammation.

Maria Koulmanda, Terry B Strom.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20635995      PMCID： PMC3070950          DOI： 10.2217/imt.10.40

Source DB:  PubMed          Journal:  Immunotherapy        ISSN： 1750-743X            Impact factor:   4.196


× No keyword cloud information.
  39 in total

Review 1.  A comprehensive review of interventions in the NOD mouse and implications for translation.

Authors:  Lisl K M Shoda; Daniel L Young; Saroja Ramanujan; Chan C Whiting; Mark A Atkinson; Jeffrey A Bluestone; George S Eisenbarth; Diane Mathis; Aldo A Rossini; Scott E Campbell; Richard Kahn; Huub T C Kreuwel
Journal:  Immunity       Date:  2005-08       Impact factor: 31.745

2.  Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles.

Authors:  J C Brüning; J Winnay; S Bonner-Weir; S I Taylor; D Accili; C R Kahn
Journal:  Cell       Date:  1997-02-21       Impact factor: 41.582

Review 3.  Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: implications for intrahepatic grafts.

Authors:  Neal R Barshes; Samuel Wyllie; John A Goss
Journal:  J Leukoc Biol       Date:  2005-02-22       Impact factor: 4.962

4.  Alpha1-antitrypsin monotherapy prolongs islet allograft survival in mice.

Authors:  Eli C Lewis; Leland Shapiro; Owen J Bowers; Charles A Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-10       Impact factor: 11.205

5.  IL-2 receptor-targeted cytolytic IL-2/Fc fusion protein treatment blocks diabetogenic autoimmunity in nonobese diabetic mice.

Authors:  X X Zheng; A W Steele; W W Hancock; K Kawamoto; X C Li; P W Nickerson; Y Li; Y Tian; T B Strom
Journal:  J Immunol       Date:  1999-10-01       Impact factor: 5.422

6.  A function for interleukin 2 in Foxp3-expressing regulatory T cells.

Authors:  Jason D Fontenot; Jeffrey P Rasmussen; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2005-10-16       Impact factor: 25.606

Review 7.  Immunology of insulin-dependent diabetes mellitus.

Authors:  A A Rossini; J P Mordes; A A Like
Journal:  Annu Rev Immunol       Date:  1985       Impact factor: 28.527

8.  TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells.

Authors:  Marc Veldhoen; Richard J Hocking; Christopher J Atkins; Richard M Locksley; Brigitta Stockinger
Journal:  Immunity       Date:  2006-02       Impact factor: 31.745

9.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance.

Authors:  G S Hotamisligil; N S Shargill; B M Spiegelman
Journal:  Science       Date:  1993-01-01       Impact factor: 47.728

Review 10.  The role of alpha 1-antitrypsin deficiency in the pathogenesis of immune disorders.

Authors:  S N Breit; D Wakefield; J P Robinson; E Luckhurst; P Clark; R Penny
Journal:  Clin Immunol Immunopathol       Date:  1985-06
View more
  3 in total

1.  α-1-antitrypsin gene delivery reduces inflammation, increases T-regulatory cell population size and prevents islet allograft rejection.

Authors:  Galit Shahaf; Hadas Moser; Eyal Ozeri; Mark Mizrahi; Avishag Abecassis; Eli C Lewis
Journal:  Mol Med       Date:  2011-06-09       Impact factor: 6.354

Review 2.  Current and future immunomodulation strategies to restore tolerance in autoimmune diseases.

Authors:  Jeffrey A Bluestone; Hélène Bour-Jordan
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-11-01       Impact factor: 10.005

3.  Antibody combination therapy targeting CD25, CD70 and CD8 reduces islet inflammation and improves glycaemia in diabetic mice.

Authors:  T Alkhamis; J Barbic; T Crnogorac-Jurcevic; R E Greenlaw; M Peakman; S Jurcevic
Journal:  Clin Exp Immunol       Date:  2012-11       Impact factor: 4.330
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.